Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
L Zhou, Q Yu, G Wei, L Wang, Y Huang, K Hu, Y Hu… - BMC cancer, 2021 - Springer
Background Multiple myeloma (MM) is a major health concern. Understanding the different
burden and tendency of MM in different regions is crucial for formulating specific local …
burden and tendency of MM in different regions is crucial for formulating specific local …
Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis
Multiple myeloma (MM) is the second most frequent malignancy of blood, and information on
disease burden of MM is limited in develo** countries. We aimed to estimate the …
disease burden of MM is limited in develo** countries. We aimed to estimate the …
Incidence and mortality of multiple myeloma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
J Liu, W Liu, L Mi, X Zeng, C Cai, J Ma, L Wang… - Journal of hematology & …, 2019 - Springer
Background The accurate information about burden of multiple myeloma (MM) at national
and provincial level remains unknown in China. Methods Following the general analytical …
and provincial level remains unknown in China. Methods Following the general analytical …
Global disparities in patients with multiple myeloma: a rapid evidence assessment
There are disparities in outcomes for patients with multiple myeloma (MM). We evaluated the
influence of sociodemographic factors on global disparities in outcomes for patients with …
influence of sociodemographic factors on global disparities in outcomes for patients with …
[HTML][HTML] Cannabis, one health, and veterinary medicine: cannabinoids' role in public health, food safety, and translational medicine
S Ritter, L Zadik-Weiss, O Almogi-Hazan… - Rambam Maimonides …, 2020 - ncbi.nlm.nih.gov
Public health is connected to cannabis with regard to food, animal feed (feed), and
pharmaceuticals. Therefore, the use of phytocannabinoids should be examined from a One …
pharmaceuticals. Therefore, the use of phytocannabinoids should be examined from a One …
Multiple myeloma in Latin America
D Gómez-Almaguer, VT de Moraes Hungria - Hematology, 2022 - Taylor & Francis
ABSTRACT Introduction Multiple myeloma in Latin America (LATAM) face multiple
challenges related to the lack of resources according to low-and middle-income in the …
challenges related to the lack of resources according to low-and middle-income in the …
Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016
VT de Moraes Hungria… - British journal of …, 2020 - Wiley Online Library
Limited data are available regarding contemporary multiple myeloma (MM) treatment
practices in Latin America. In this retrospective cohort study, medical records were reviewed …
practices in Latin America. In this retrospective cohort study, medical records were reviewed …
Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma
JS Malta, LP Silveira, PLM Drummond… - Current Medical …, 2021 - Taylor & Francis
Purpose Multiple myeloma (MM) is a rare but treatable hematological cancer, which makes
the health-related quality of life (HRQoL) an important patient-report outcome measure in …
the health-related quality of life (HRQoL) an important patient-report outcome measure in …
[HTML][HTML] Real-world evidence of epidemiology and clinical outcomes in multiple myeloma, findings from the registry of hemato-oncologic malignancies in Colombia …
ABTRACT Introduction/Background Multiple Myeloma (MM) is a plasma cell derived clonal
disorder that represents around 1% of all newly diagnosed neoplasms. Limited data …
disorder that represents around 1% of all newly diagnosed neoplasms. Limited data …
Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey …
The incidence of multiple myeloma (MM) has increased in the last 20 years, particularly in
middle and low-middle income countries. Access to diagnostic and prognostic tests and the …
middle and low-middle income countries. Access to diagnostic and prognostic tests and the …